According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is 0,85ย โฌ. In 2022 the company made an earnings per share (EPS) of 0,92ย โฌ a decrease over its 2021 EPS that were of 0,94ย โฌ.